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Neurogenin3During pancreas development, endocrine and exocrine cells arise from a common multipotent progenitor
pool. How these cell fate decisions are coordinated with tissue morphogenesis is poorly understood. Here we
have examined ductal morphology, endocrine progenitor cell fate and Notch signaling in Ngn3−/− mice,
which do not produce islet cells. Ngn3 deﬁciency results in reduced branching and enlarged pancreatic duct-
like structures, concomitant with Ngn3 promoter activation throughout the ductal epithelium and reduced
Notch signaling. Conversely, forced generation of surplus endocrine progenitor cells causes reduced duct
caliber and an excessive number of tip cells. Thus, endocrine progenitor cells normally provide a feedback
signal to adjacent multipotent ductal progenitor cells that activates Notch signaling, inhibits further endocrine
differentiation and promotes proper morphogenesis. These results uncover a novel layer of regulation
coordinating pancreas morphogenesis and endocrine/exocrine differentiation, and suggest ways to enhance
the yield of beta cells from stem cells.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The exocrine and endocrine compartments of the adult pancreas
can be viewed as two independent organs. The distinct functions of
the exocrine pancreas (release of digestive enzymes into the
duodenum) and the endocrine pancreas (regulation of glucose
homeostasis) are reﬂected by the different genetic programs
responsible for the function of each tissue. Furthermore, the
important pathologies associated with the pancreas can be divided
into those that affect the endocrine (e.g. diabetes) or exocrine (e.g.
pancreatic cancer, pancreatitis) compartments, and the clinical
practice of islet transplantation shows that endocrine and exocrine
functions are separable anatomically.
However, it is now clear that during development, a common
group of multipotent progenitor cells in the embryonic gut, expres-
sing speciﬁc markers such as Foxa1, Foxa2, Pdx1, Ptf1a and Sox9, give
rise to both the endocrine and exocrine pancreas (Burlison et al.,
2008; Gao et al., 2008; Gu et al., 2002; Kawaguchi et al., 2002; Martin
et al., 2007; Seymour et al., 2007). Recently, Zhou and Meltonproposed a “tip-trunk” model in an effort to explain tissue dynamics
during pancreas development (Zhou et al., 2007). According to this
model, tip cells expressing Carboxypeptidase A1 (Cpa1) constitute a
multipotent progenitor pool; as they divide, these tip cells leave
behind elongated branches (trunks) that contain the progenitors for
both ducts and islets. Over time, Neurogenin3+ (Ngn3+) endocrine
progenitor cells appear within the trunks, delaminate, and differen-
tiate into hormone-producing cells that later coalesce into the islets of
Langerhans. In parallel, tip cells differentiate into acinar cells and
subsequently secrete digestive enzymes into the ductal network.
While this model provides a coherent description of pancreas
development, it gives little insight into the regulatory signals that
govern exocrine and endocrine differentiation or the mechanisms by
which the size and form of the endocrine and exocrine compartments
are coordinated.
One molecular pathway previously implicated in binary differen-
tiation decisions of the developing pancreas is Notch signaling
(Apelqvist et al., 1999; Gradwohl et al., 2000). Several studies have
shown that Notch pathway activation in the epithelium prevents
differentiation to either endocrine fates (Greenwood et al., 2007; Hald
et al., 2003; Jensen et al., 2000a; Murtaugh et al., 2003), while down
regulation of Notch causes a premature induction of Ngn3, leading to
precocious endocrine differentiation and depletion of the progenitor
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2000b). By analogy to cell fate decisions in Drosophila, it has been
proposed that the induction of Ngn3 expression occurs via the process
of lateral inhibition, where Delta-Notch intercellular signaling
between neighboring cells determines their fate (Apelqvist et al.,
1999; Skipper and Lewis, 2000; Wang et al., 2010). However, this
proposal still awaits experimental validation. Notch signaling has also
been implicated in the development of the exocrine pancreas.
Overexpression of Notch prevents acinar cell differentiation and
causes the formation of enlarged, cystic and undifferentiated ducts
(Esni et al., 2004; Hald et al., 2003; Murtaugh et al., 2003). In any case,
Notch signaling is usually investigated in the context of one
compartment only, namely exocrine or endocrine. Whether the
morphogenesis of the endocrine and exocrine compartments of the
pancreas is interdependent and coordinated, and whether this occurs
via Notch signaling, remains unexplored.
Here we investigate how the embryonic endocrine pancreas
affects the development of the exocrine pancreas, in particular the
fundamental process of ductal branching morphogenesis. To this end
we have employed genetic lineage tracing in mice deﬁcient for Ngn3,
which completely lack endocrine cells (Gradwohl et al., 2000). We
report that endocrine progenitor cells, but not their differentiated
progeny, are necessary for correct branching morphogenesis of the
ductal tree. In addition, we provide evidence that endocrine
progenitor cells inhibit further endocrine differentiation in adjacent
epithelial cells through non-cell autonomous regulation of Notch
signaling. These results demonstrate a novel mechanism whereby
differentiation and cellular delamination are coordinated to balance
tissue composition and morphogenesis during the formation of a
mature organ. Moreover, these results suggest that Notch-mediated
lateral inhibition may account for some of the difﬁculties encoun-
tered in attempts to derive beta cells from embryonic stem cells in
vitro.Materials and methods
Mice
Mouse strains used in this study were Ngn3-CreER (serving as
Ngn3 nulls) (Wang et al., 2010), ROSA-LSL-YFP (Srinivas et al., 2001),
BAC transgenic Ngn3-Cre (Schonhoff et al., 2004), Pax4−/− (Sosa-
Pineda et al., 1997), Pax6−/− (St-Onge et al., 1997) and compound
Pdx1-Cre; Rosa-LSL-Nicd (Murtaugh et al., 2003).
The joint ethics committee (IACUC) of the Hebrew University and
Hadassah Medical Center approved the study protocol for animal
welfare. The Hebrew University is an AAALAC International accredited
instituteExplant cultures
The dorsal pancreatic bud from embryonic day (e)12.5 mouse
embryos was excised under a dissecting microscope in Hank's
balanced salts solution (HBSS). The explants were cultured in
DMEM supplied with 10% fetal bovine serum, containing 100 U/ml
penicillin and 100 μg/ml streptomycin. Explants were cultured on
microporous membranes and no medium was added on top of the
ﬁlter, so that the tissue grew at the air/medium interface. Medium
was changed every other day. Gamma Secretase Inhibitor (GSI) was
added to explants for 15–42 h. We used either Gamma secretase
inhibitor XX, (Calbiochem, cat # 565789, used at a ﬁnal concentration
of 100 nM), or LY-411575 (Stemgent, cat #04-0054, used at a ﬁnal
concentration of 100 nM). To mark Ngn3+ cells from the Ngn3-CreER
allele, explants were treated with 4-hydroxy tamoxifen (Sigma, used
at a ﬁnal concentration of 5 μM).Immunostaining
Staining was performed on 5-μm thick parafﬁn sections of
dissected guts (e15.5) or isolated pancreata (e15.5-P3). Tissue was
ﬁxed in 4% buffered zinc-formalin for 2 hours at 4c, dehydrated in an
ethanol series, cleared in histoclear and embedded in Paraplast
(Kendall). When required, antigen retrieval was performed using a
pressure cooker. Whole-mount staining was performed essentially as
described previously (Ahnfelt-Ronne et al., 2007b).
Primary antibodies used in this study included: guinea pig anti-
insulin (1:500; DAKO), Armenian hamster anti-muc1 (1:250; Labvi-
sion), rabbit anti-amylase (1:100; Sigma), biotinylated DBA (1:250;
Vector), rabbit anti-carboxypepetidase1 (1:200; Rockland), guinea
pig and rabbit anti-Pdx1 (1:2,500; a generous gift of Chris Wright),
mouse anti-E-cadherin (1:50; BD), rabbit anti-ptf1a (1:2000), rabbit
anti-Ngn3 (1:500) and mouse anti-Nkx6.1 (1:100) from Beta Cell
Biology Consortium, rabbit anti Cleaved Notch Intracellular Domain
(1:100; Cell Signaling), rabbit anti Hes1 (1:1500; (Zong et al., 2009)),
rabbit anti Sox9 (1:250; Chemicon), guinea pig anti-Ngn3 (1:500; a
generous gift of Maike Sander), goat anti-GFP antibody (1:500;
Abcam), goat anti-Jagged1 (Santa Cruz, 1:100), Rabbit anti-Hnf-1beta
(Santa Cruz, 1:200), Rabbit anti-Hnf-6 (Santa Cruz, 1:100), Goat anti-
Amylase (Santa Cruz, 1:100),rabbit anti-Cre (a generous gift of
Christoph Kellendonk, 1:3000) (Kellendonk et al., 1999) and rabbit
anti-Cre (1:100, Novus). For DNA counterstain we used dapi (Sigma).
Rabbit anti-Hes1 and rabbit anti-NICD require ampliﬁcation using TSA
kit (Perkin Elmer) (Ahnfelt-Ronne et al., 2007b). Secondary anti-
bodies were from Jackson immunoresearch, used at 1:200. Immuno-
ﬂuorescence images were captured on a Nikon C1 confocal
microscope or Olympus FV1000.
Morphometric analysis of duct volume in explants
Confocal z-stacks of pancreas explants were subjected to morpho-
metric analysis using a customMATLAB code: ducts were identiﬁed by
three conditions (i) DAPI-negative regions, which are (ii) enclosed by,
and include, a MUC1-bright boundary region, and are (iii) surrounded
by DAPI-stained nuclei. Total duct volume per explant was then
calculated as the total duct area per z-stack multiplied by the image
separation, and the result was normalized by the total sample volume.
Morphometric analysis of network density in vivo
Confocal z-stacks for pancreas tissue aged e16.5-P1were subjected
to morphometric analysis using a custom MATLAB code. Ducts were
ﬁrst identiﬁed as described above. For each image, the fraction of
pancreatic volume at a distance of x from the ducts was evaluated by
calculating the size of a border region of thickness x pixels around the
ducts (see schematic in Supplemental Fig. 3S). Results were averaged
over all samples per genotype. High duct penetration predicts full
coverage of pancreatic volume at smaller values of x than low duct
penetration.
Results
Ngn3 deﬁciency perturbs branching morphogenesis
To determine if and how endocrine cell formation affects
branching morphogenesis of the pancreas, we examined the structure
of the ductal tree in Ngn3-deﬁcient pancreata (Wang et al., 2010). As
previously shown by Gradwohl and colleagues (Gradwohl et al.,
2000), Ngn3-deﬁcient embryos at all stages completely lack endo-
crine hormone-producing cells. Surprisingly, whole-mount staining
for the ductal marker Muc1 revealed a dramatic alteration in the
morphology of the developing ductal tree in the pancreas of e13.5 and
e15.5 Ngn3-deﬁcient embryos (Fig. 1A, Supplemental Fig. 1S and
Fig. 1. Abnormal branching of the pancreas in Ngn3−/− embryos. A, representative images of e15.5 Ngn3−/− (right) and control (left) littermates, stained for Muc1. Note thicker
central tubes in mutants, marked by arrowheads. Whole-mount staining, 5 optical confocal sections superimposed. A similar pattern was observed in a total of 10 Ngn3−/− embryos
from 6 litters (see also Supplemental Fig. 1S). B, e13.5 Ngn3−/− and control littermates, stained for Muc1 and the tip marker Ptf1a. Central areas in the mutant epithelium have fewer
Ptf1a+ cells (arrowheads), suggesting reduction in the number of tip cells. Amylase is not detected at this stage (data not shown), indicating that these are multipotent progenitors
and not differentiated acinar cells. Whole mount staining, 7 optical confocal sections stacked. Scale bar 100 μm.
28 J. Magenheim et al. / Developmental Biology 359 (2011) 26–36Supplemental movies 1+2). Mutant tubes were enlarged and dilated,
and had fewer branches. The abnormal thickness of mutant ducts was
most apparent in central areas of the pancreas, where Ngn3+ cells are
normally located. Notably, mutant ducts were dilated, not elongated,
and the overall size of the mutant pancreas was unchanged. The
pattern of dilated ducts with larger lumens in Ngn3 mutants was
apparent also when staining for other markers, including E-Cadherin,
Hnf1beta and Hnf6 (Supplemental Fig. 2S). Mutant ducts appeared
normal at e12.5, suggesting that the phenotype develops during the
secondary transition of pancreas development, the time of massive
Ngn3+ cell formation and delamination in wild type (Supplemental
Fig. 2S). Staining for the tip markers Ptf1a and Cpa1 (Zhou et al., 2007)
revealed that themutant epithelium had fewer tip cells, particularly in
central areas (Fig. 1B and Supplemental Fig. 2S). The duct phenotype
in Ngn3−/− embryos was even more pronounced in explant cultures,
probably due to their ﬂatter structure that is more easily captured in
microscopic analysis. As shown in Fig. 2A, the explanted mutant
epithelium had thicker, less branched tubes. Furthermore, staining of
wild-type explants for Pdx1 revealed the emergence of discretestructural units, likely the precursors of acini; in contrast, the mutant
epithelium stained homogenously for Pdx1 and lacked these units,
consistent with reduced branching (Fig. 2B). Morphometric quanti-
ﬁcation of Muc1-stained tissue in explants conﬁrmed that the duct
volume was increased in Ngn3 mutants (Fig. 2C). Due to early
postnatal lethality of Ngn3−/−mutants (Gradwohl et al., 2000), it was
impossible to examine the functional impact of altered duct/exocrine
morphology in adult mutant mice. 3D reconstruction of the ductal
system in newborns suggested that Ngn3mutants still have abnormal
ducts (Supplemental movie 3). Visual inspection of confocal slices and
Z-stacks from e16.5, e18.5 and p1 mutants revealed a sparser ductal
network, indicative of reduced branching. However, quantiﬁcation of
network density did not assign statistical signiﬁcance to these trends
(supplemental Fig. 3S). It is possible that ductal morphology and
branching pattern in Ngn3 mutants begin to normalize towards birth,
likely related to the decline of Ngn3 expression at this stage.
Regardless of the question of normalization, acinar differentiation
beyond the tip formation stage appears to be normal in Ngn3mutants,
reﬂecting a speciﬁc role of Ngn3+ cells in the allocation of tip cells.
Fig. 2. Abnormal branching in explanted Ngn3−/− pancreata. A, e12.5 explants cultured on ﬁlters for 2 days and stained for Muc1. Note thicker, less branched epithelium inmutants.
Whole-mount staining, 5 optical confocal sections stacked. B, Pdx1 staining of explants. Note discrete acinar-like structures in heterozygotes (yellow asterisks) and their absence in
null mutants. Scale bars in A,B 100 μm. C, quantiﬁcation of duct volume in explants as a function of Ngn3 gene dosage, measured as the surface area stained for Muc1.
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endocrine progenitor cells or by their progeny, we examined the
structure of ducts in Pax4−/− and Pax6−/− embryos, which have
normal Ngn3+ cells but lack beta cells and alpha cells, respectively
(Sosa-Pineda et al., 1997; St-Onge et al., 1997). The ductal tree in both
mutants appeared normal, compared with wild-type littermates
(Supplemental Fig. 4S). In sum, these results show that Ngn3-
deﬁcient pancreata have a defective ductal structure, and suggest
that endocrine progenitor cells (but not their differentiated progeny)
participate in shaping the morphogenesis of the exocrine pancreas.A gamma secretase inhibitor induces ductal thinning and excessive tip
formation in wild type but not Ngn3 mutants.
We reasoned that if endocrine progenitors are necessary for
proper ductal morphogenesis, and their absence impedes branching,
then forced generation of surplus Ngn3+ cells might cause opposite
effects on ductal morphogenesis and branching. To test this prediction
we treated wild-type e12.5 explants with a gamma secretase inhibitor
(GSI). As previous studies have shown (Duvillie et al., 2006), the
application of GSI caused a rapid (observed within 15 h) and
signiﬁcant increase in the number of Ngn3+ cells (Fig. 3A). This was
accompanied by dramatic thinning of Muc1+ epithelial tubes
(observed after ~2 days of treatment) (Figs. 3A,B), reﬂecting wide-
spread Ngn3+ cell delamination. Strikingly, the expression domain of
the tip marker Carboxypeptidase A1 (Cpa1), normally conﬁned to the
periphery of explants, expanded to central areas upon GSI treatment
(Fig. 3B). Similar results were obtained with a chemically different
GSI, supporting the speciﬁcity of the phenotype to inhibition of
gamma secretase (Supplemental Fig. 5S).Cpa1 marks both multipotent tip cells and differentiated acinar
cells. To verify that GSI indeed enhances the formation of tip cells,
we harvested explants after either 2 or 3 days treatment with GSI,
and co-stained for Cpa1 and the acinar marker Amylase. After 2 days,
treated explants had expanded areas of Cpa1+Amylase- cells; after
3 days, these cells were mostly Cpa1+ Amylase+ acinar cells
(Supplemental Fig. 6S). These results are consistent with GSI
triggering the initial formation of multipotent tip cells, followed by
acinar differentiation.
To determine if GSI shifted Ngn3+ from an endocrine to a
tip/acinar fate, as suggested by a recent study (Cras-Meneur et al.,
2009), we treated explants for 2 days with GSI and co-stained for
Ngn3, Insulin and Muc1. This treatment caused depletion of Ngn3+
cells, and the appearance of both excessive insulin+ cells and excessive
tips (Supplemental Fig. 7S and Fig. 3B). Thus, our results suggest that
GSI induces the formation of excessive Ngn3+ cells which go on to
become endocrine, as previously shown; in parallel, GSI induces the
formation of excessive tip cells.
Next, we considered two possibilities: GSI could impact the
developing ducts and tips directly, or indirectly via an acceleration
of Ngn3+ cell formation. To distinguish between these possibilities,
we treated Ngn3−/− explants with GSI. As shown in Fig. 3C, Ngn3−/−
explants were refractory to the duct-thinning effect of GSI, mostly in
central areas where Ngn3+ cells form. This indicates that excessive
formation of Ngn3+ cells is responsible for ductal thinning and
increased tip formation in GSI-treated wild-type explants.
Taken together, these results demonstrate that Ngn3+ endocrine
progenitor cells are important determinants of duct size and
structure. Moreover, they support the notion that endocrine pro-
genitors control tip formation and branching of the embryonic
pancreas.
Fig. 3. Gamma secretase inhibitor produces the reverse phenotype of Ngn3 deﬁciency: excessive Ngn3+ cells, ductal thinning and excessive Cpa1+ tip cells. A, Muc1 and Ngn3
staining of e12.5 wild-type explants cultured on ﬁlters for 2 days and incubated with GSI during the last 15 h. Note excessive formation of Ngn3+ cells and thinning of duct-like
structures in GSI-treated samples. B, Muc1 and Cpa1 staining of wild-type e12.5 explants cultured on ﬁlters for 3 days and incubated with GSI during the last 42 h. GSI-treated
explants showmore Cpa1+ cells in central areas (left panels, yellow circles) and thinner, sparser tubes (right panels, yellow arrowheads). C, the impact of gamma secretase inhibitor
on the epithelium is Ngn3-dependent. Muc1 staining of e12.5 wild-type and Ngn3−/− deﬁcient explants, cultured on ﬁlters for 2 days and incubated with GSI during the last 42 h.
While GSI treatment causes dramatic ductal thinning in wild-type explants, the thicker central tubes of Ngn3mutants are resistant to the drug. Note that GSI does seem to have some
effects in the periphery of Ngn3−/− explants, perhaps inducing the differentiation of committed acinar precursors. Scale bars 100 μm.
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The most plausible explanation for the thicker ducts in Ngn3−/−
pancreata is a mass effect: duct diameter could be a function of the
number of cells delaminating from, or remaining within, the epithe-
lium. This scenario requires that (1) Ngn3 expression is induced within
the ductal epithelium prior to delamination; and (2) in Ngn3−/−
mutants, cells activating the Ngn3 promoter survive, but fail to
delaminate and are therefore retained within the epithelium, causing
an increase in duct diameter. To test these predictions, we ﬁrst
immunostained e15.5 wild-type embryonic pancreata for Ngn3, Muc1
and E-Cadherin (demarcating cell boundaries). Ngn3+ nuclei could
clearly be identiﬁed in Muc1+ cells in contact with the lumen,
indicating that Ngn3 expression precedes delamination (Supplemental
Fig. 8S). This observation is consistent with a recent report that
documented the initiation of delamination byNgn3 (Gouzi et al., 2011).
Therefore, delamination or retention of Ngn3+ cells contributes cell
autonomously to the thickness of ducts. To determine the fate of Ngn3-
expressing cells in Ngn3−/− mice, we next employed genetic lineage
tracing, allowing for the detection of these cells despite the absence of
Ngn3 protein expression. Ngn3 deﬁciency was combined with a BAC
transgene where the Ngn3 locus drives Cre recombinase (Ngn3-Cre)
(Schonhoff et al., 2004) and a ROSA26-lox-stop-lox-YFP (Rosa-YFP)
reporter for Cre activity (Srinivas et al., 2001). In e15.5 Ngn3−/−; Ngn3-
Cre; Rosa-YFP embryos, cells that turn on the Ngn3 promoter are
permanently labeledwith YFP, such that their fate could be determined.
As expected, YFP expression was strictly dependent on the presence of
the Ngn3-Cre transgene (supplemental Fig. 9S). Recombination
occurred in Ngn3+/+ e15.5 embryos speciﬁcally in the DBA-labeled
epithelium and in the hormone-producing progeny of Ngn3+ cells
(Fig. 4A). By postnatal day 3, YFP+ cells were conﬁned to the nascent
islets, with minimal labeling of ducts and acini (Fig. 4C). Ngn3-deﬁcient
e15.5 embryos (Fig. 4B) and newborn mice (Fig. 4D) had abundant
YFP+ cells that were conﬁned to ducts, with few scattered acinar cells.
This result provides clear evidence that in the absence of Ngn3 protein,
cells expressing the Ngn3 promoter survive, fail to delaminate andremain integrated within the ductal epithelium. To examine the fate of
Ngn3+ cells lacking Ngn3 protein using another Cre driver, we took
advantage of the CreER gene that was knocked into the Ngn3 locus for
its disruption (Wang et al., 2010). Explants containing one or two
copies of CreER (causing heterozygosity or deﬁciency of Ngn3,
respectively) and a YFP reporter were treated with 4-hydroxy
tamoxifen. The spectrum of labeled cells in these explants was more
restricted, likely reﬂecting lower levels of nuclear Cre in these mice
compared with the BAC transgenic (a combination of lower expression
level and tamoxifen dependency). In heterozygous explants, recombi-
nation was observed in endocrine cells. In Ngn3-deﬁcient explants
(lacking endocrine cells), recombination was largely restricted to Muc1
ductal cells, with minimal labeling in acinar cells (Supplemental Fig.
9S). This observation is in agreement with a similar lineage tracing
study published recently (Wang et al., 2010). Taken together, these
results provide a plausible explanation for the impact of Ngn3+
endocrine progenitor cells on duct morphology: the delamination of
these cells is a signiﬁcant contributor to overall cell number in ducts,
and hence to duct thickness. In addition, decreased tip formation in
Ngn3−/− embryos may contribute to duct thickness. Therefore, the
thickness of ducts in wild-type mice, in Ngn3−/− mice and in GSI-
treated explants is determined by the number of Ngn3+ cells that have
delaminated from the epithelium.
Ngn3 protein restricts the number of ductal cells turning on the Ngn3 gene
A closer examination of the lineage tracing data revealed that in
embryonic and newborn Ngn3−/− mice, the majority of DBA-labeled
duct cells were YFP+, indicating that they or their ancestors have
activated the Ngn3 promoter at one time or another (Figs. 4B,D,
Supplemental Fig. 11S). This is in sharp contrast to the situation in
wild-type animals, where Ngn3+ cells are born in the ductal
epithelium, but delaminate such that postnatal ducts contain mostly
cells that have never activated the Ngn3 gene promoter. Speciﬁcally,
in e15.5 embryos we found that 25% of DBA+ cells in wild-type
animals were YFP+, while 78% of DBA+ cells in Ngn3−/− littermates
Fig. 4. Fate of endocrine progenitor cells lacking the Ngn3 gene. A, B, e15.5 Ngn3-Cre; Rosa-YFP mice containing wild-type or null Ngn3 alleles, stained for Dba (duct marker), Cpa1
(acinar marker at this age) and YFP (marks historical activation of Ngn3 promoter). In Ngn3−/− embryos, most progeny of Ngn3-expressing cells remain conﬁned within the Dba+
epithelium, while a minority appear to be acinar. C, D, postnatal day 3, wild-type and Ngn3−/− littermates, stained for Dba, YFP, Insulin and Amylase. Most ductal cells inmutants but
not in controls are YFP+, indicating that most mutant duct cells have activated the Ngn3 promoter sometime in their history. Scale bar 100 μm. In panels B and D, arrows point to
labeled ducts and arrowheads point to scattered labeled acinar cells.
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pancreata, cells expressing the Ngn3 protein prevent the activation of
the Ngn3 gene promoter in adjacent ductal epithelial cells. According
to this view, Ngn3−/− mutants lack this non-cell autonomous
feedback signal, and hence most ductal epithelial cells turn on the
Ngn3 promoter. Since this does not result in Ngn3 protein accumu-
lation in the mutant, there are no phenotypic consequences (other
than Cre-mediated activation of the YFP reporter in Ngn3-Cre; Rosa-
YFP mice), and Ngn3−/− cells that turn on the Ngn3 promoter remain
in ducts. This result is consistent with the hypothesis that endocrine
differentiation in pancreatic epithelium is controlled by a process of
lateral inhibition, as proposed by many studies of pancreas develop-
ment (Apelqvist et al., 1999; Jensen et al., 2000a; Wang et al., 2010).
Moreover, it shows that most trunk epithelial cells and not just a small
subset have the potential to become endocrine cells, though in
practice very few do.
Evidence for Ngn3-mediated lateral inhibition of cell fate via Notch
In the central nervous system, lateral inhibition is mediated via
Notch signaling. The core pathway involves upregulation of Notch
ligand expression in differentiating epithelial cells (becoming neuro-
nal progenitors), which acts to maintain high Notch activity in
adjacent cells and thus prevent their differentiation (Bray, 2006;
Fortini, 2009; Kopan and Ilagan, 2009; Lewis, 1998). This process
causes a mosaic distribution of delaminating neuronal progenitors,while maintaining a self-renewing population of neuronal stem cells
within the epithelium. Ngn3 expression is known to be repressed by
the Notch target Hes1, suggesting that a similar mechanism might be
operating in pancreatic epithelium (Lee et al., 2001).
We sought to test the hypothesis that inhibition of endocrine
differentiation is mediated by direct communication of Ngn3-
expressing cells with adjacent ductal epithelial cells prior to
delamination. Speciﬁcally, we speculated that Ngn3+ endocrine
progenitors (which have low Notch activity) turn on a Notch ligand,
which acts to enhance Notch activity in immediately adjacent ductal
epithelial cells and thus prevent Ngn3 expression and endocrine
differentiation. This idea is supported by a previous study suggesting
that Delta-like 1 (Dll1), a key Notch ligand, restrains the number of
Ngn3+ cells in the developing pancreas (Apelqvist et al., 1999). The
predictions of such a model are that (1) Ngn3+ cells should express
Notch ligand/s; (2) Notch signaling should be active in epithelial cells
adjacent to Ngn3+ cells; and (3) Notch signaling should be reduced in
Ngn3−/− mutants. Using commercially available antibodies directed
against Dll1 we failed to obtain immunostaining of sufﬁcient quality
(not shown). In a previous study no reduction in the mRNA level of
Dll1 was found in Ngn3+ cells expressing different levels of Ngn3
protein (Wang et al., 2010), although others have shown that Dll1
mRNA can be induced by Ngn3 protein (Gasa et al., 2004; Treff et al.,
2006). An alternative means for inducing Notch ligand activity in
Ngn3+ cells would be to downregulate an inhibitor. It was shown
recently that Jagged1 acts as a competitive inhibitor of Notch signaling
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ligands (Benedito et al., 2009; Golson et al., 2009). We therefore
examined Jagged1 expression in the pancreatic epithelium. As shown
in Fig. 5A, Ngn3+ cells have reduced levels of Jagged1 protein. Co-
staining for Jagged1 and Cre in embryos expressing Cre under the
Ngn3 promoter generated similar results, namely lower levels of
Jagged1 in Cre+ epithelial cells (Fig. 5B). These results are consistent
with two recent reports that showed higher levels of Jagged1mRNA in
Ngn3-negative cells versus Ngn3-positive cells (Soyer et al., 2010) and
in Ngn3+ cells expressing lower than normal levels of Ngn3 protein
(Wang et al., 2010). These data provide a potential molecular
mechanism for increased Notch ligand activity (e.g. Dll1) in Ngn3+
cells.
To examine Notch activity as a function of Ngn3 expression more
directly, we determined the expression pattern of the Notch
intracellular domain (Nicd), as a readout for cells in which Notch is
active and hence endocrine differentiation is unlikely. In addition, we
documented the expression pattern of Hes1, a repressor of Ngn3
expression and a direct target of Notch signaling. As shown in Figs. 6A,
B, multiple cell nuclei in the wild-type ductal epithelium were Hes1+Fig. 5. Jagged1 is downregulated in Ngn3-expressing epithelial cells. A. Parafﬁn sections from
cells. B. Parafﬁn sections from e14.5 pancreata of Ngn3-CreER+/− mice stained for Cre, E-caand Nicd+. Ngn3+ cells were never Hes1+ or Nicd+, consistent with
the notion that these cells have low Notch pathway activation, and
supporting the validity of our immunostaining (Supplemental Fig.
10S). Furthermore, Nicd+ and Hes1+ cells were never clustered but
rather interspersed between Nicd/Hes1-negative cells that were often
Ngn3+; this pattern is consistent with a lateral inhibition paradigm.
As an additional control, we examined sections of transgenic embryos
that overexpressed Nicd throughout the pancreas (Pdx1-Cre; Rosa-
LSL-Nicd) (Murtaugh et al., 2003). As expected and further supporting
the validity of immunostaining, transgenic sections had more
homogenous staining for both Nicd and Hes1 compared with wild
types (Supplemental Fig. 10S). Strikingly, the ductal epithelium in
Ngn3−/− embryos had reduced levels of Hes1 and Nicd (Figs. 6A,B),
suggesting that Ngn3+ cells enhance Notch activity in adjacent cells
to prevent their endocrine differentiation. The fact that GSI, a known
inhibitor of Notch signaling, induces Ngn3 expression in the majority
of pancreatic epithelial cells (Fig. 3) provides further evidence that
interference with Notch signaling disrupts the lateral inhibition
mechanism that prevents the formation of Ngn3 cells within the
ductal epithelium.e15.5 wild-type pancreata stained for Ngn3, E-Cad and Jagged1. Asterisks point to Ngn+
d and Jagged1. Arrows and asterisks point to Cre+ cells. Scale bars 10 μm.
Fig. 6. Ngn3 protein controls expression of Notch signaling components in the developing pancreatic epithelium. A, parafﬁn sections from e15.5 pancreata stained for Notch
intracellular domain (Nicd, green) and Hes1 (brown). Note a reduction in the level of Nicd and Hes1 in the Ngn3−/− epithelium. Black lines and arrows highlight abnormally long
stretches of Hes1-negative ductal epithelial cells in Ngn3−/− mice. Scale bars 10 μm. B, quantiﬁcation of Hes1-negative ductal epithelial cells in Ngn3 wild-type vs. Ngn3 null
embryos (n=3 embryos per genotype). We counted the number of lumen-contacting cells in a row that are Hes1-negative. Bars represent the length distribution of such strings.
Note that Ngn3−/− ducts have much longer strings of Hes1-negative epithelial cells. C, epithelial cells in Ngn3−/− e15.5 embryos express normal levels of Sox9 despite past
activation of the Ngn3 promoter, indicating that Ngn3 protein is required for downregulation of Sox9 expression in endocrine progenitor cells. Scale bars 50 μm.
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Sox9, a transcription factor marking the early pancreatic epithe-
lium, has emerged as an important regulator of Ngn3 expression,
endocrine differentiation, and a target of Notch signaling (Seymour
et al., 2007; Seymour et al., 2008; Zong et al., 2009). Normally, Ngn3
and Sox9 expression in the epithelium are mutually exclusive
((Seymour et al., 2007, 2008) and Fig. 6C). This suggests that Sox9
expression is shut-off after the onset of the endocrine differentiation
program, but the mechanism underlying this downregulation is not
known. Strikingly, we found that epithelial cells which have turned on
the Ngn3 promoter, but failed to accumulate Ngn3 protein, remained
Sox9+ (Fig. 6C). This result is consistent with the recent ﬁnding that
Sox9mRNA is upregulated in Ngn3-deﬁcient cells (Wang et al., 2010),
and suggests that Ngn3 protein is required cell autonomously for the
downregulation of Sox9 expression. Thus, Ngn3 and Sox9 are linked
via a negative feedback loop: Sox9 positively controls Ngn3
expression, and Ngn3 negatively controls the expression of Sox9.Discussion
Endocrine progenitor cells control branching morphogenesis
A fundamental problem in organ morphogenesis is how the
development of different tissue compartments is coordinated. The
problem applies to compartments of distinct origins, for example
epithelium versus blood vessels, as well as compartments that share a
common origin, such as the endocrine and the exocrine pancreas. We
have shown here that the endocrine compartment is a novel and
important regulator of exocrine pancreas morphogenesis. In the
absence of endocrine progenitor cells (but not their differentiated
progeny), ducts become enlarged, and fewer branches are formed.
Using genetic lineage tracing we found that in the absence of Ngn3
protein, epithelial cells activating the Ngn3 promoter are formed and
survive, but fail to delaminate. This ﬁnding explains the thicker ducts
observed in Ngn3−/− pancreata, particularly in central areas where
Ngn3+ cells are normally abundant. According to this model, the
control of duct morphology by endocrine progenitor cells simply
Fig. 7.Model for the effects of Ngn3 protein on pancreatic epithelium. The presence of
Ngn3 protein biases epithelial cells cell autonomously towards an endocrine fate, and
against a tip/branching fate. Activation of the Notch pathway in adjacent cells biases
against an endocrine fate, manifesting lateral inhibition of endocrine differentiation.
Instead, adjacent cells adopt a tip/branching fate. Ngn3-dependent downregulation of
Jagged1 could support Notch activation in adjacent cells by potentiating the activity of
Dll1 or another Notch ligand in Ngn3-expressing cells. Ngn3 may also directly increase
the expression of Dll1 or other ligands. In mutants lacking Ngn3 protein, lateral
inhibition of endocrine differentiation is absent, and all epithelial cells are directed to
futile activation of the Ngn3 promoter. In parallel, the signal favoring tip/branching fate
is absent, resulting in the formation of thick, unbranched tubes.
34 J. Magenheim et al. / Developmental Biology 359 (2011) 26–36reﬂects the number of cells that delaminate or are retained within the
epithelium. Notably, mutant ducts were wider, not longer, which was
reﬂected also by the overall normal size of Ngn3-deﬁcient pancreata.
Why Ngn3 deﬁciency causes enlargement of duct diameter and not
length is an intriguing open question that merits further examination.
Planar cell polarity signaling has been shown to control tube diameter
versus length in other systems (Karner et al., 2009), and thus
represents an interesting candidate mediator of the observed
phenotype.
More surprisingly, Ngn3+ cells appear to positively control the
formation of tip cells, the multipotent progenitors that lead theway to
new ductal branches, from which ductal, endocrine cells and acinar
cells will emerge (Zhou et al., 2007). The control of tip formation by
Ngn3+ cells cannot be readily explained by the number of
delaminating or retained Ngn3+ cells. Rather, it appears that Ngn3+
cells communicate with adjacent trunk epithelial cells and enhance
their likelihood of becoming tip cells. This scenario is consistent with
the emerging view, based on genetic lineage tracing (Solar et al.,
2009) and time-lapse studies (Puri and Hebrok, 2007), that pancreatic
branches are formed laterally, from within trunks, rather than by
splitting of existing tip cells. According to this model, the pancreas
grows via cycles of trunk cells giving rise to lateral tip, which in turn
leave behind new trunks. Our results establish Ngn3+ cells as
important regulators of this cyclic process, controlling proper
branching pattern and tissue balance of the pancreas.
The molecular basis for the control of branching by endocrine
progenitor cells remains to be investigated. We propose that non-cell
autonomous induction of Notch signaling in the ductal epithelium by
Ngn3+ cells (see below) controls this process, by increasing the
numbers of adjacentNicd+ andHes1+ cells. The role of Hes1 expression
and Notch signaling in tip formation has not been directly studied
before.However, consistentwith the suggestion above, Hes1 expression
was reported in distal tips (Apelqvist et al., 1999; Wang et al., 2005).
Additionally, increased Notch activity was shown to inhibit acinar
differentiation (Esni et al., 2004;Hald et al., 2003;Murtaughet al., 2003),
potentially biasing towards a multipotent tip phenotype.
One intriguing observation in our study is the augmentation of tip
formation by GSI treatment. We showed that this drug impacted
branching morphogenesis via its enhancing effect on the number of
Ngn3+ cells (since Ngn3−/− explants are resistant to the effect).
However, GSI is also thought to directly inhibit Notch activity, which
according to our model should inhibit tip formation. How can these
two seemingly contradictory functions of GSI be reconciled? We
speculate that the discrepancy reﬂects the complexity of Notch
signaling that includes GSI-resistant pathways. In support of this view,
a recent study (Nakhai et al., 2008) has shown that development of
the exocrine pancreas depends on the downstream Notch component
Rbpj, but not on Notch1/2; this suggests that a non-canonical Notch
signaling (which is GSI-independent, as we show here) controls
exocrine pancreas development. More detailed genetic studies will be
required to resolve this issue. An alternative explanation to the pro-
tip/acinar effect of GSI is that it shifts Ngn3+ progenitors, cell
autonomously, from endocrine to exocrine fate, as proposed recently
(Cras-Meneur et al., 2009). Our results do not support such a model,
since we found that GSI increased, rather than decreased, the number
of Insulin+ cells in parallel to the enhanced formation of tips
(Supplemental Fig. 7S). In addition, in lineage tracing experiments
using the Ngn3-Cre BAC transgenic we did not observe augmentation
of labeled acinar cells after GSI treatment (data not shown). One
potentially important difference between our experiments and Cras-
Meneur et al. is the shorter duration of our protocol, which perhaps
prevented indirect effects on the rate of proliferation of newly formed
acinar cells. In summary, we prefer a model where GSI triggers the
formation of Ngn3+ cells, which go on to become endocrine, and in
parallel via lateral interactions boost the formation of tip cells that will
become acinar.Additionally, the documentation of epithelial cells that turned on
the Ngn3 promoter but failed to accumulate Ngn3 protein merits
some attention. These cells were instructed to become endocrine, and
have started to express the key marker for endocrine differentiation.
Previous studies have documented that no endocrine cells are formed
in the absence of Ngn3 protein (Gradwohl et al., 2000), but the fate of
these cells was rarely examined before (Cras-Meneur et al., 2009;
Wang et al., 2010). Our results clearly show that Ngn3 protein is
essential for delamination, potentially by activation of an expression
module of epithelial to mesenchymal transition (Gouzi et al., 2011;
Rukstalis and Habener, 2007). Remarkably, the bias of Ngn3-
expressing cells towards an endocrine fate is reversible. Thus, in the
absence of Ngn3 protein, these cells survive and remain within the
epithelium, adoptingwhat seems to be a normal ductal cell phenotype
(based on general morphology and expression of the duct markers
Hnf1beta and HNF6). As shown here, this has multiple consequences
on pancreas morphogenesis. In our experiments using both Ngn3-Cre
and Ngn3-CreER, the fate of Ngn3+ cells in Ngn3 mutants was
primarily ductal. We propose that the occasional labeling seen in
acinar cells (whichwas also reported byWang et al., 2010, although to
a larger extent) reﬂects events of lateral tip formation, branching and
acinar differentiation from previously labeled trunk cells.Notch-mediated lateral inhibition restricts endocrine
pancreas development
A key ﬁnding of the current study is that Ngn3 expression in a
proportion of epithelial cells is important to prevent the expression of
Ngn3 in additional, adjacent epithelial cells. In fact, in the absence of
Ngn3 protein, most duct cells activate the Ngn3 gene promoter at some
point. This provides clear evidence for a process of lateral inhibition
operating during pancreas endocrine development (Apelqvist et al.,
1999; Wang et al., 2010). We note that our ability to observe this
previously unrecognized phenomenon may be a result of the speciﬁc
experimental systemwe employed. In our experimentswe used genetic
lineage tracing, which documents the cumulative number of Ngn3-
expressing cells up to the time of observation. Examination of short-
term Ngn3 promoter activity would have probably missed this
phenotype, since lateral activation of Ngn3 is likely asynchronous,
such that at any given time no signiﬁcant enhancement of Ngn3
promoter activity is observed.
Lateral inhibition during neuronal development is mediated by
Notch signaling. It is thought that downregulation ofNotch signaling in
epithelial cells derepresses proneural genes (homologs of Ngn3) and
initiates a neuronal progenitor program that includes cellular
delamination. At the same time, these progenitors upregulate Notch
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epithelial cells, preventing their differentiation and maintaining a self
renewal state. Consequently, a mosaic pattern of neuronal differenti-
ation and self renewal is generated (Bray, 2006; Fortini, 2009; Kopan
and Ilagan, 2009). To test if pancreatic endocrine differentiation
follows the neuronal paradigm,we examined the dependenceof Notch
signaling markers on Ngn3. Consistent with a Notch-mediated lateral
inhibition model, Ngn3+ cells do not stain for Nicd and express
minimal if any levels of the Notch pathway target Hes1 (Fig. 6 and
Supplemental Fig. 10S); furthermore, either Ngn3 or Nicd/Hes1
expressing cells are not clustered but rather mosaic, as expected in a
lateral inhibition setting. Most strikingly, we found that the presence
of Ngn3 protein is critical for the expression of Hes1, as well as Nicd, in
adjacent cells within the pancreatic ductal epithelium. Together, these
observations suggest a plausible molecular mechanism for lateral
inhibition during endocrine differentiation in the pancreas. According
to this model, reduced Notch activity in a subset of duct cells
derepresses Ngn3 expression and initiates endocrine development.
Ngn3 protein, perhaps via a cell autonomous upregulation of Notch
ligand activity (see below), causes the upregulation of Notch activity
in adjacent epithelial cells (as reﬂected by staining for Notch
intracellular domain and Hes1 expression). Hes1+; Nicd+ duct cells
are biased against an endocrine fate, and remain in the epithelium
(model, Fig. 7). These cells are likely responsible for expansion of the
epithelium.
Recently, Wang et al.(2010) reported that Ngn3-expressing cells
have higher Hes1 expression when Ngn3 gene dose is reduced.
Superﬁcially, this seems to contradict our results of reduced Hes1
expression in the ductal epithelium of Ngn3−/− mice. In fact, the
results of the two studies are complementary and in agreement with
ourmodel. We propose that in wild-type ducts, Ngn3+ cells have very
low levels of Hes1, while adjacent Ngn3-negative cells have high
levels. In the epithelium of Ngn3−/− embryos lateral interactions are
attenuated; Ngn3+ cells do not downregulate Hes1, and adjacent
Ngn3-negative cells do not upregulate Hes1. Thus the mutant
epithelium has on average more Hes1 than wild-type Ngn3+ cells
(as shown by Wang et al.), but less Hes1 than wild-type Ngn3-
negative cells (as suggested by our in-situ staining).
It is tempting to speculate that the non-cell autonomous, Ngn3-
induced Notch activity is responsible not only for lateral inhibition of
endocrine differentiation, but also for the Ngn3-dependency of tip
formation and branching. Consistent with this idea, Hes1 was shown to
be a tip marker (Apelqvist et al., 1999; Wang et al., 2005). However,
further studieswill be required to test howNotch controls tip formation.
It also remains unclear how Ngn3+ cells activate Notch signaling
in adjacent cells. In this study and in a previous paper (Wang et al.,
2010) we could not identify a reduction in the expression of any Notch
ligand in cells that express the Ngn3 gene promoter but lack Ngn3
protein. A potential explanation comes from recent reports that
Jagged1 mRNA is upregulated in Ngn3-deﬁcient cells (Wang et al.,
2010), and is under-represented in Ngn3+ cells (Soyer et al., 2010),
and from our observation that expression of Jagged1 protein is
reduced in Ngn3+ epithelial cells in wild-type mice (Fig. 5). Given
recent reports that Jagged1 inhibits Notch signaling during early
pancreasmorphogenesis (Golson et al., 2009) and in developing blood
vessels (Benedito et al., 2009), it is possible that lateral inhibition in
the pancreas is mediated by downregulation of inhibitory Jagged1
expression in Ngn3+ cells, permitting activation of Notch signaling in
adjacent cells through other Delta-family ligands whose level of
expression need not change (model, Fig. 7). In support of this model,
the expression of Manic Fringe, which is essential for the inhibitory
effect of Jagged at the receiving cell, is restricted to Ngn3+ cells
(Golson et al., 2009; Svensson et al., 2009; Xu et al., 2006). Thus, the
control of Jagged1 and Manic Fringe expression by Ngn3 could be the
basis for the lateral interactions controlling endocrine and tip fates.
Further experiments will be required to test this possibility.Conclusions
In summary, we propose that expression of Ngn3 cell autono-
mously biases epithelial cells towards an endocrine fate, and against a
tip fate (and consequently branching and acinar differentiation). At
the same time, Ngn3 protein has an opposite non-cell autonomous
effect: by triggering Notch activity in adjacent epithelial cells it biases
these cells against an endocrine fate, and favors a tip/branching fate
(Fig. 7). Thus, our results expose an unappreciated level of regulation,
which coordinates the development of two seemingly unrelated
compartments of the pancreas.
These ﬁndings may have practical implications for efforts to direct
the differentiation of embryonic stem cells (ESC) towards transplant-
able insulin-producing beta cells. Recent progress in this area allows
the efﬁcient derivation of ESC-derived Pdx1+ pancreatic epithelial
cells (Borowiak et al., 2009; Chen et al., 2009; D'Amour et al., 2005,
2006; Kroon et al., 2008). However, the yield of endocrine
differentiation remains extremely low for unclear reasons. One
theoretical possibility is that only a subset of pancreatic epithelial
cells is competent to become endocrine, and that ESC culture
conditions select against this competent population. Our results
suggest thatmost if not all pancreatic epithelial cells residing in trunks
are in principle capable of turning on Ngn3 expression and hence
adopting an endocrine fate; in fact this seems to be the default fate of
trunk cells, which is normally prevented by signals from adjacent
Ngn3+ cells. We speculate that lateral inhibition could be one factor
accounting for the low numbers of endocrine cells formed in ESC
cultures. Interference with lateral inhibition communication might
help improve the yield of pancreatic endocrine cells from ESC.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.08.006.
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